Department of Gastric Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
J Surg Oncol. 2013 Feb;107(2):130-5. doi: 10.1002/jso.23252. Epub 2012 Sep 4.
To explore the time and pattern of recurrence of proximal gastric cancer and estimate the risk factors and prognostic factors for it. Considering these risk factors, postoperative adjuvant therapies and follow-up program can be individualized.
The data of 135 recurrence proximal gastric cancer patients were extracted and analyzed.
In 135 recurrence patients, the median time to recurrence was 14.0 months, 116 (85.9%) patients had recurrences within 2 years. Loco-regional recurrence was the most prevalent pattern. Hematogenous metastasis was next prevalent pattern in which the liver was the most common organ. Peritoneal recurrence occurred in 32 patients. Five patients recurred in distant lymph nodes. The deeper invasion was associated with higher incidence of hematogenous metastases and peritoneal recurrence. The histological type, depth of invasion, and lymph node metastasis were independent risk factors for overall recurrence. While, negative lymph nodes counts were another independent risk factors for early recurrence. Patients with systemic recurrence and early recurrence patients had poorer prognosis.
Total gastrectomy and adequate lymph nodes dissection were rational choice of proximal gastric cancer with deeper invasion. Pathologic predictors of invasion, histological type, lymph nodes metastasis and negative lymph node counts could guide individualized, risk-oriented adjuvant treatment, and follow-up plan.
探讨近端胃癌的复发时间和模式,并评估其相关的危险因素和预后因素。考虑到这些风险因素,可以为患者制定个体化的术后辅助治疗和随访方案。
本研究提取并分析了 135 例近端胃癌复发患者的资料。
在 135 例复发患者中,中位复发时间为 14.0 个月,116 例(85.9%)患者在 2 年内复发。局部复发是最常见的复发模式,血行转移次之,其中肝脏是最常见的转移部位。32 例患者发生腹膜转移,5 例患者发生远处淋巴结转移。浸润深度越深,发生血行转移和腹膜转移的风险越高。组织学类型、浸润深度和淋巴结转移是总复发的独立危险因素,而阴性淋巴结计数是早期复发的另一个独立危险因素。发生全身复发和早期复发的患者预后较差。
对于浸润深度较深的近端胃癌,全胃切除术和充分的淋巴结清扫是合理的选择。浸润程度、组织学类型、淋巴结转移和阴性淋巴结计数等病理预测因素可以指导个体化、风险导向的辅助治疗和随访计划。